Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | NQO2 | P16083 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ACP3 | P15309 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7654681 | 1.00 | GPR84 (0.43) | GPR84CYP1A2CYP2C19CYP2C9MTNR1A | |
| SCHEMBL9819905 | 0.89 | CYP1A2 (0.46) | GPR84CYP1A2CYP2C19CYP2C9MTNR1A | |
| SCHEMBL6001657 | 0.89 | CYP1A2 (0.46) | GPR84CYP1A2CYP2C19CYP2C9MTNR1A | |
| SCHEMBL30424192 | 0.83 | SIGMAR1 (0.48) | GPR84CYP1A2CYP2C19CYP2C9MTNR1A | |
| SCHEMBL6028071 | 0.82 | TLR8 (0.50) | GPR84CYP1A2CYP2C19CYP2C9MTNR1A | |
| SCHEMBL9216856 | 0.82 | CYP1A2 (0.48) | GPR84CYP1A2CYP2C19CYP2C9MTNR1A | |
| SCHEMBL5830948 | 0.79 | GPR84 (0.59) | GPR84CYP1A2CYP2C19CYP2C9MTNR1A | |
| SCHEMBL9800436 | 0.79 | CYP1A2 (0.58) | GPR84CYP1A2CYP2C19CYP2C9MTNR1A | |
| SCHEMBL2106557 | 0.79 | MTNR1A (0.42) | GPR84CYP1A2CYP2C19CYP2C9MTNR1A | |
| SCHEMBL5609954 | 0.79 | SIGMAR1 (0.50) | GPR84CYP1A2CYP2C19CYP2C9MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118234717-A | Bicyclic heteroaromatic compounds and their use as pest control agents | PI工业有限公司 | 2024-06-21 | — | — | CN | disclosed |
| EP-3625215-B1 | FORMIMIDAMIDINE COMPOUNDS USEFUL AGAINST PHYTOPATHOGENIC MICROORGANISMS | PI INDUSTRIES LTD (IN) | 2023-09-13 | — | — | EP | disclosed |
| WO-2023144711-A1 | 1,2,3-TRIAZOLE CARBONYL SULFONYLAMIDE COMPOUNDS AND USE THEREOF | PI INDUSTRIES LTD. (IN) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023084473-A1 | BICYCLIC HETEROAROMATIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS | PI INDUSTRIES LTD. (IN) | 2023-05-19 | — | — | WO | disclosed |
| CN-115427411-A | 5- (3- (ethylsulfonyl) pyridin-2-yl) -pyrazolo [1,5-a ] pyrimidine derivatives and related compounds as pesticides for crop protection | PI工业有限公司 | 2022-12-02 | — | — | CN | disclosed |
| CN-113454063-A | 3-substituted phenylamidine compounds, preparation method and application thereof | PI工业有限公司 | 2021-09-28 | — | — | CN | disclosed |
| CN-113061089-A | Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof | 凯瑞康宁生物工程（武汉）有限公司 | 2021-07-02 | — | — | CN | disclosed |
| CN-108283000-B | Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof | 凯瑞康宁生物工程（武汉）有限公司 | 2021-04-13 | — | — | CN | disclosed |
| CN-111670180-A | Fluoroalkenyl compounds, process for their preparation and their use | PI工业有限公司 | 2020-09-15 | — | — | CN | disclosed |
| US-20200148635-A1 | FORMIMIDAMIDINE COMPOUNDS USEFUL AGAINST PHYTOPATHOGENIC MICROORGANISMS | PI INDUSTRIES LTD. (IN) | 2020-05-14 | — | — | US | disclosed |
| CN-110770210-A | Novel amidine compounds | PI工业有限公司 | 2020-02-07 | — | — | CN | disclosed |
| WO-2018211442-A1 | FORMIMIDAMIDINE COMPOUNDS USEFUL AGAINST PHYTOPATHOGENIC MICROORGANISMS | PI INDUSTRIES LTD. (IN) | 2018-11-22 | — | — | WO | disclosed |
| US-6376510-B1 | ADMINISTERING A ALKOXY- AND ACYLOXY-SUBSTITUTED ARALKYL AND ARALKENYL BIS QUATERNARY AMMONIUM DERIVATIVES OF CYCLIC ALKANOL DIESTERS TO A HUMAN AS MUSCLE RELAXANTS | NEWLAXANT LLC | 2002-04-23 | — | — | US | disclosed |
| US-6274623-B1 | DI- OR POLY-ALKOXY-OR ACYLOXY-SUBSTITUTED ARALKYL AND ARAKENYL QUATERNARY AMMONIUM DERIVATIVES OF CYCLIC AMINOALKANOL DIESTERS SUCH AS BIS(N-(3,4-DIPROPIONYLOXY-BENZYL)GRANATANINIUM-3-ALPHA-YL)ADIPATE DIBROMIDE | NEWLAXANT LLC | 2001-08-14 | — | — | US | disclosed |
| US-6274757-B1 | REACTING AN HYDROXY AMINE CORRESPONDING COMPOUND WITH DICHLORO COMPOUND | NEWLAXANT LLC | 2001-08-14 | — | — | US | disclosed |
| CN-1280578-A | Bis-quaternary ammonium derivatives as neuromuscular relaxants | NEWLAKSONT CO LTD (US) | 2001-01-17 | — | — | CN | disclosed |
| EP-1025099-A1 | BIS-QUATERNARY AMMONIUM DERIVATIVES AS NEUROMUSCULAR RELAXANTS | Gyermek, Laszlo (US) | 2000-08-09 | — | — | EP | disclosed |
| US-5990124-A | ALKOXY AND/OR ACYLOXY DI- AND POLY-SUBSTITUTED ARALKYL AND ARALKENYL BIS-QUATERNARY AMMONIUM DERIVATIVES OF CYCLIC ALKANOL DIESTERS; SUCH AS BIS(N-(4-ACETOXY-3-METHOXYBENZYL) TROPANIUM-3-YL)-3,6-ENDOMETHYLENE-1,2,3,6-TETRAHYDROPHTHALATE | GYERMEK LASZLO (US) | 1999-11-23 | — | — | US | disclosed |
| WO-1999021854-A1 | BIS-QUATERNARY AMMONIUM DERIVATIVES AS NEUROMUSCULAR RELAXANTS | NEWLAXANT LLC (US) | 1999-05-06 | — | — | WO | disclosed |
| EP-0279681-A2 | Saturated heterocyclic carboxamide derivatives | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1988-08-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200148635-A1 | FORMIMIDAMIDINE COMPOUNDS USEFUL AGAINST PHYTOPATHOGENIC MICROORGANISMS | PADI4, PADI1, PADI2 | GPR84 2097/4885CYP1A2 2031/4885CYP2C19 2648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.